权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Validation of Nuclear Morphology as a Biomarker of Aging and Aging-Related Phenotypes

核形态作为衰老和衰老相关表型生物标志物的验证

基本信息

批准号：
10199917
负责人：
Denis Wirtz
金额：
$ 59.27万
依托单位：
JOHNS HOPKINS UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2018
资助国家：
美国
起止时间：
2018-09-30 至 2023-05-31
项目状态：
已结题

来源：
https://reporter.nih.gov/project-details/10199917
关键词：
Actins Adhesives Age Aging American B-Lymphocytes Biological Biological Markers Biomechanics Cell Aging Cell Nucleus Cell physiology Cells Cellular Morphology Cessation of life Characteristics Chronic Disease Chronology Clinical Complex Data Dermal Dermatology Dermatopathology Descriptor Development Discrimination Disease Elderly Etiology Fibroblasts Gender Human Individual Institutes Interphase Lamin Type A Lamins Lymphocyte Measurement Measures Molecular Morphology Nuclear Nuclear Lamin Nuclear Protein Outcome Participant Patient Recruitments Patients Pharmacology Phenotype Population Study Prospective cohort study Proteins Race Research Research Personnel Resources Risk Shapes Source Squamous Cell Structure Technology Testing Tissues Universities Validation age related aging population behavioral health biomarker validation biophysical techniques cohort frailty healthy aging multiple chronic conditions nanobiotechnology novel protein expression protein structure recruit single cell technology

项目摘要

Abstract Alterations in the nuclear protein lamin and associated structures in the nucleus have been identified as a source of nuclear morphology changes that markedly impact overall cellular function. These changes in nuclear morphology are thought to drive molecular changes that influence a wide range of aging-related phenotypes and chronic disease states. Importantly, we have recently used high-throughput measurements of nuclear morphology to identify outstanding biomarkers of chronological age. We hypothesize that these age-related changes in nuclear morphology are highly correlated with chronological age in healthy individuals, and that a specific age-related biological change in lamin underlies this phenomenon. Building on our prior development of these high-throughput and accurate measures of nuclear morphology, we propose here to further develop this biological discovery and technology as a valid and reliable biomarker of aging-related biological mechanisms. We hypothesize that changes in nuclear morphology can be rapidly measured and that age-related alterations correlate with aging-related phenotypes and disease states independently of chronological age, consistent with a measure of cellular biological age. To test these hypotheses and move results toward clinical utility, we have assembled a highly synergistic, interdisciplinary team propose the following specific aims: Aim 1. Using our validated single-cell technologies, we will develop a mechanistic understanding of how descriptors of nuclear morphology in human dermal fibroblasts and B-lymphocytes are robust biomarkers of aging in healthy individuals. Aim 2. Establish the accuracy and precision with which our proposed biomarkers identify chronological age for individuals with varying demographic, behavioral, and health characteristics. Aim 3. We will examine the strength with which morphological biomarkers discriminate individuals with adverse phenotypes and outcomes of aging, and at risk for the development of these, from healthy older adults, above and beyond chronological age.

摘要